Fortress Biotech (FBIO) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $8.8 million.
- Fortress Biotech's Profit After Tax rose 13306.74% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$26.7 million, marking a year-over-year increase of 7839.06%. This contributed to the annual value of -$120.9 million for FY2024, which is 2160.11% up from last year.
- Per Fortress Biotech's latest filing, its Profit After Tax stood at $8.8 million for Q3 2025, which was up 13306.74% from $15.5 million recorded in Q2 2025.
- Fortress Biotech's 5-year Profit After Tax high stood at $15.5 million for Q2 2025, and its period low was -$68.5 million during Q4 2021.
- Over the past 5 years, Fortress Biotech's median Profit After Tax value was -$28.8 million (recorded in 2024), while the average stood at -$32.7 million.
- In the last 5 years, Fortress Biotech's Profit After Tax tumbled by 23434.85% in 2021 and then surged by 15372.61% in 2025.
- Quarter analysis of 5 years shows Fortress Biotech's Profit After Tax stood at -$68.5 million in 2021, then rose by 16.15% to -$57.4 million in 2022, then surged by 49.54% to -$29.0 million in 2023, then increased by 9.21% to -$26.3 million in 2024, then skyrocketed by 133.54% to $8.8 million in 2025.
- Its Profit After Tax stands at $8.8 million for Q3 2025, versus $15.5 million for Q2 2025 and -$24.7 million for Q1 2025.